Fukuda Denshi
Basic Information
- Stock Code
- 6960
- Industry
- Electrical Machinery
- Category Detail
- Commercial & Industrial Machinery
- Prefecture
- Tokyo
- Establishment Year
- July 1948
- Listing Year
- May 1982
- Official Website
- https://www.fukuda.co.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Fancom, Sumitomo Seika, Terumo, Uemura Kogyo, PHC Holdings, Technomedica, Rion, Nihon Kohden, Yagami, Japan M.D.M., Nakanishi, Olympus, Cyberdyne
Overview
Fukuda Denshi is a leading company in the medical electronics field founded in 1948, possessing high technological capabilities in the development, manufacturing, and sales of medical equipment centered on electrocardiographs.
Current Situation
Fukuda Denshi achieved consolidated net sales of approximately ¥140.3 billion and operating profit of approximately ¥26.5 billion for the fiscal year ending March 2024, continuing solid management in the medical electronics equipment industry. Its core business is manufacturing and selling electrocardiographs and vital sign monitors, maintaining stable shares domestically and internationally. Actively pursuing technological innovation, it has introduced cutting-edge products such as AI-based atrial fibrillation risk assessment devices. It emphasizes sustainability through environmentally friendly air purifiers and the establishment of a safety testing center. Leveraging a community-based sales network with over 220 locations nationwide. Sponsors professional sports for social contributions, marking its 85th anniversary in 2024 as a venerable company advancing mid- to long-term growth strategies. It plans to strengthen total solutions in response to the diversification and sophistication of medical equipment.
Trivia
Interesting Facts
- Has a history of developing Japan's first domestically produced electrocardiograph.
- Sponsors both professional baseball and soccer.
- Highly regarded in the industry for its in-house developed blood pressure pulse wave testing devices.
- Pioneering company in applying AI technology to medical equipment.
- Holds naming rights for the Fukuda Denshi Arena soccer stadium.
- Equipment used in JAXA's space clinical research.
- Multiple Good Design Awards for medical equipment.
- Stable shareholder structure and financial position backed by parent company.
- Strength in vital sign monitor development in the medical equipment field.
- Adopts temperature array method recorder technology in products.
Hidden Connections
- Pursues community ties through naming rights for J.League JEF United Ichihara Chiba's home stadium.
- Advances product supply and joint development through partnership with Omron Healthcare.
- Collaborates with JAXA to provide space clinical medical equipment.
- Subsidiary operates medical oxygen concentrator rental business.
- Builds solid customer base in electrocardiograph market for small- and medium-sized hospitals.
- Nippon Life Insurance, banks, and trust banks listed as major shareholders.
- Has many medical institutions adopting AI-analysis-equipped electrocardiographs.
- Installed safety testing center in Shirai City for thorough quality control.
Future Outlook
Growth Drivers
- Advancement of electrocardiographs and medical equipment using AI technology
- Increasing demand for home healthcare and nursing equipment due to aging society
- Expansion of sales networks targeting domestic and international medical institutions
- Development of environmentally friendly medical equipment and strengthened sustainability
- Diversification of product lineup through medical equipment partnerships
- Acceleration of product expansion into preventive medicine and health management fields
Strategic Goals
- Maintain and expand top domestic share in medical equipment
- Global rollout of AI-integrated medical equipment
- Strengthen and promote sustainability initiatives
- Build and reinforce local medical support systems
- Create innovative products through expanded R&D investment
- Enhance brand value through professional sports sponsorship
Business Segments
Medical Equipment Manufacturing and Sales
- Overview
- Develops, manufactures, and sells high-performance medical equipment for medical institutions.
- Competitiveness
- Product lineup leveraging advanced AI technology and in-house development capabilities
- Customers
-
- Hospitals
- Clinics
- Medical equipment distributors
- Medical offices
- Health management centers
- Products
-
- Electrocardiographs
- Vital sign monitors
- Blood pressure pulse wave testing devices
- Ultrasound diagnostic devices
- Air purifiers
Medical Equipment Sales Partnerships
- Overview
- Provides other companies' products through sales partnerships to meet a wide range of medical needs.
- Competitiveness
- Extensive product range and sales network
- Customers
-
- Medical institutions
- Emergency service providers
- Nursing homes
- Products
-
- AED
- Ventilators
- Cardiac pacemakers
Safety Testing Services
- Overview
- Provides high-quality testing services at the Shirai Business safety testing center.
- Competitiveness
- Testing expertise compliant with international standards
- Customers
-
- Medical equipment manufacturers
- Research institutions
- Products
-
- Safety testing
- Environmental testing
Competitive Advantage
Strengths
- Long years of technological accumulation in medical electronics
- Top domestic share in electrocardiographs
- Extensive sales network with over 220 locations
- Utilization of advanced AI analysis technology
- Diverse product lineup
- Robust sales partnership system
- Good Design Award track record
- Ownership of safety testing center
- Long-term stable financial base
- Brand enhancement through professional sports sponsorship
Competitive Advantages
- Proprietary high-performance electrocardiograph technology integrated with AI analysis
- Strong trusted relationships with medical institutions
- High market coverage through multifaceted product offerings
- Provision of value-added services such as safety testing
- Prompt response via nationwide direct sales and agent network
- Diversified product assortment through partnerships with multiple medical equipment manufacturers
- Brand value enhancement via Good Design Award
- Product competitiveness through substantial R&D investment
Threats
- Risk of approval delays due to stricter medical device regulations
- Competitors' technological innovations and pricing pressures
- Suppression of hospital equipment introductions due to healthcare cost controls
- Emergence of local competitors in overseas markets
- Cost increase risks from exchange rate fluctuations
- Increasing new entrants and intensifying market competition
- Emergence of advanced technologies overcoming technical barriers
Innovations
2023: Development of AI-equipped atrial fibrillation risk assessment device
- Overview
- Developed a device capable of highly accurate detection of hidden atrial fibrillation by integrating AI into electrocardiographs.
- Impact
- Contributes to improved diagnostic efficiency and early treatment.
2024: Launch of multi-function electrocardiograph FCP-9800
- Overview
- Commercialized a multi-function electrocardiograph with enhanced waveform analysis to meet medical site needs.
- Impact
- Contributes to sales expansion and market share maintenance.
2022: Air purification, sterilization, and deodorization device FDS-01 wins Good Design Award
- Overview
- Functionality and design of medical site air purification equipment recognized.
- Impact
- Contributes to product brand enhancement and sales promotion.
2021: Development of blood pressure pulse wave testing device VS-2500 system
- Overview
- Launched new high-precision measurement and operability-balanced blood pressure pulse wave testing device.
- Impact
- Expanded adoption in domestic medical institutions.
Sustainability
- Development of energy-saving equipment to reduce environmental impact
- Efforts to reduce medical waste
- Enhanced quality assurance through safety testing center
- Sustainable medical support activities for local communities
- In-house environmental education and awareness initiatives